Skip to main content
Clinical Trials/CTRI/2024/03/063488
CTRI/2024/03/063488Active, not recruitingNot Applicable

Developing screening tool for de Quervain tenosynovitis among computer users.

Jeet Dey1 site in 1 country300 target enrollmentStarted: March 11, 2024Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
300
Locations
1
Primary Endpoint
To create a rapid assessment tool that aids in prompt identification and treatment of the disease.

Study Overview

Brief Summary

De Quervain’s tenosynovitis is a painful and debilitating musculoskeletal disorder that often afflicts computer users due to repetitive thumb and wrist movements. The study employs a multidisciplinary approach, combining clinical assessments, ergonomic evaluations, and self-reported data to create a comprehensive screening instrument. Additionally, the research explores the prevalence of De Quervain’s tenosynovitis within the computer user population and investigates the associated risk factors. The findings of this research contribute to the understanding and management of this condition, potentially reducing its impact on computer-dependent populations and enhancing their overall well-being.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18.00 Year(s) to 40.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Computer usage more than 5 hours for 5 to 6 days in a week, diagnosed case of de quervain since 1 month, presence of pain and discomfort in thumb region, pain worsen during work and difficulty in gripping objects, numeric pain rating scale less than 7 and patients willing to participate.

Exclusion Criteria

  • Previous history of wrist trauma or surgery, Rheumatoid arthritic patients, patients having any neurological deficits, patients on any pain reliving medication since 1 month, person having any congenital deformity, patients outside the age bracket, and patients not willing to participate.

Outcomes

Primary Outcomes

To create a rapid assessment tool that aids in prompt identification and treatment of the disease.

Time Frame: 6 months

Secondary Outcomes

  • Cost effectiveness(8 weeks)

Investigators

Sponsor
Jeet Dey
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Jeet Dey

Amity Institute of Physiotherapy

Study Sites (1)

Loading locations...

Similar Trials